Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Top Cited Papers
Open Access
- 30 November 2008
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 54 (5), 1081-1088
- https://doi.org/10.1016/j.eururo.2008.06.071
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active SurveillanceJournal of Urology, 2008
- PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy OutcomeJournal of Urology, 2008
- Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridizationLaboratory Investigation, 2007
- Effect of Nutritional Supplement Challenge in Patients with Isolated High-Grade Prostatic Intraepithelial NeoplasiaUrology, 2007
- The incidence of high‐grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first‐time saturation needle biopsy, and the subsequent risk of cancerBJU International, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Interview with Jack Schalken: PCA3 and its Use as a Diagnostic Test in Prostate CancerEuropean Urology, 2006
- APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate CancerClinical Chemistry, 2006
- Risk of Prostate Cancer on First Re-Biopsy Within 1 Year Following a Diagnosis of High Grade Prostatic Intraepithelial Neoplasia is Related to the Number of Cores SampledJournal of Urology, 2006
- Characteristics of insignificant clinical T1c prostate tumorsCancer, 2004